Literature DB >> 28537400

Xylopiana A, a Dimeric Guaiane with a Case-Shaped Core from Xylopia vielana: Structural Elucidation and Biomimetic Conversion.

Ya-Long Zhang1, Xu-Wei Zhou1, Xiao-Bing Wang1, Lin Wu1, Ming-Hua Yang1, Jun Luo1, Yong Yin1, Jian-Guang Luo1, Ling-Yi Kong1.   

Abstract

Xylopiana A (1), a dimeric guaiane with an unprecedented pentacyclo[5.2.1.01,2.04,5'.05,4']decane-3,2'-dione core, and three biosynthetically related intermediates, compounds 2-4, were isolated from the leaves of Xylopia vielana. Their structures and absolute configurations were determined by a combination of spectroscopic data, X-ray crystallography, electronic circular dichroism calculations, and chemical conversion. The structure of known vielanin A was revised to be compound 3. Compound 4 exerted a 3.7-fold potentiation effect on doxorubicin susceptibility at the tested concentration of 10 μM.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28537400     DOI: 10.1021/acs.orglett.7b01276

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  3 in total

1.  New anti-inflammatory guaianes from the Atlantic hydrotherm-derived fungus Graphostroma sp. MCCC 3A00421.

Authors:  Siwen Niu; Chun-Lan Xie; Jin-Mei Xia; Zhu-Hua Luo; Zongze Shao; Xian-Wen Yang
Journal:  Sci Rep       Date:  2018-01-11       Impact factor: 4.379

2.  Xylopins A-F, six rare guaiane dimers with three different connecting modes from Xylopia vielana.

Authors:  Yang-Guo Xie; Rong Yan; Xianglong Zhong; Huang Piao; Ishaq Muhammad; Xisong Ke; Shikai Yan; Yuanqiang Guo; Hui-Zi Jin; Wei-Dong Zhang
Journal:  RSC Adv       Date:  2019-03-21       Impact factor: 3.361

3.  Xyloplains A-F, six new guaiane-type sesquiterpenoid dimers from Xylopia vielana.

Authors:  Yang-Guo Xie; Weiyue Zhang; Sheng-Lan Zhu; Tao-Fang Cheng; Guo-Jing Wu; Ishaq Muhammad; Shi-Kai Yan; Yan Zhang; Hui-Zi Jin; Wei-Dong Zhang
Journal:  RSC Adv       Date:  2018-07-18       Impact factor: 3.361

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.